Journal
NEUROPHARMACOLOGY
Volume 228, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2023.109445
Keywords
Purinergic receptors; Adenosine triphosphate; Satellite glial cell; Macrophage; Neuropathic pain
Categories
Ask authors/readers for more resources
Adenosine triphosphate (ATP) acts on P2 purinergic receptors as a signaling molecule, influencing inflammatory and pro-nociceptive responses in satellite glial cells (SGCs) and macrophages. The interaction between SGCs, macrophages, and neurons through P2X and P2Y receptors plays a role in promoting and maintaining inflammation-related neuropathic pain.
Adenosine triphosphate (ATP) acts on P2 purinergic receptors as an extracellular signaling molecule. P2 purinergic receptors include P2X ionotropic receptors and P2Y metabotropic receptors. Satellite glial cells (SGCs) and macrophages express P2X and P2Y receptors. Inflammatory cytokines and pro-nociceptive mediators are released by activated macrophages and SGCs, which can act on neurons to promote excitability and firing. In the primary sensory ganglia, in response to signals of injury, SGCs and macrophages accumulate around primary sensory neurons, forming a macrophage-SGC-neuron triad. In addition to affecting the pathological alterations of inflammation-related neuropathic pain, inflammatory cytokines and pro-nociceptive mediators are released by the action of ATP on P2X and P2Y receptors in macrophages and SGCs. Macrophages and SGCs work together to enhance and prolong neuropathic pain. The macrophage-SGC-neuron triad communicates with each other through ATP and other inflammatory mediators and maintains and promotes the initiation and development of inflammation related-neuropathic pain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available